Consensus Document on the Diagnosis, Treatment and Prevention of Tuberculosis-Reference-Cited by-同舟云学术

Consensus Document on the Diagnosis, Treatment and Prevention of Tuberculosis

Published:2010-05 Issue:5 Volume:46 Page:255-274
ISSN:1579-2129
Container-title:Archivos de Bronconeumología ((English Edition))
language:en
Short-container-title:Archivos de Bronconeumología ((English Edition))

Author:

González-Martín Julià,García-García José María,Anibarro Luis,Vidal Rafael,Esteban Jaime,Blanquer Rafael,Moreno Santiago,Ruiz-Manzano Juan

Publisher

Elsevier BV

Reference72 articles.

1. WHO Report 2009. Global Tuberculosis Control: epidemiology, strategy, financing. World Health Organization. WHO/HTM/TB/2009.411. WHO Report; 2008.

2. Surveillance of Tuberculosis in Europe-Euro TB. Report on tuberculosis cases notified in 2006. Institut de Veille Sanitaire, Saint Maurice, France. March 2008. Available from: www.eurotb.org.

3. Grupo Español de Micobacteriología (GEM). Situación de las resistencias a fármacos de Mycobacterium tuberculosis en España;Jiménez;Rev Esp Quimioter,2008

4. Anti-tuberculosis Drug Resistance in the World. Report no.4. The WHO/IUATLD Global Project on anti-tuberculosis Drug Resistance Surveillance 2002-2007. World Health Organization; 2008.

5. Purpose of quality standards for Infectious Diseases;Gross;Clin Infect Dis,1994

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applied Artificial Intelligence and Prospect of Internet of Everything (IoE) for the Detection of Tuberculosis;Applied Artificial Intelligence;2024-05-24

2. ¿Tuberculosis, sarcoidosis o ambas?;Revista Clínica de Medicina de Familia;2023-12-01

3. Computer aided detection of tuberculosis using two classifiers;Biomedical Engineering / Biomedizinische Technik;2022-09-26

4. LARYNGEAL TUBERCULOSIS – A NEGLECTED DISEASE THAT CAN MIMIC LARYNGEAL CARCINOMA;International Journal of Health Services Research and Policy;2021-04-26

5. Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management;Frontiers in Immunology;2019-01-09